AdAlta Limited (the Company) was admitted to the official list of ASX Limited (ASX) on Thursday, 18 August 2016.
Official quotation of the Company’s ordinary shares will commence at 11:45 am AEST on Monday, 22 August 2016. The Company has raised $10,000,000 pursuant to the offer under its prospectus dated 8 July 2016 (Prospectus) by the issue of 40,000,000 million ordinary shares at an issue price of $0.25 per share.
Quoted securities: |
76,425,758 fully paid ordinary shares |
ASX code: |
1AD |
Time: |
11:45 am AEST |
Date: |
Monday, 22 August 2016 |
ASX Trade abbreviation: |
ADALTA |
ISIN: |
AU0000001AD2 |
Home branch: |
Melbourne |
Industry classification: |
GICS 3520 – Pharmaceuticals, Biotechnology and Life Sciences |
Corporate office: |
15/2 Park Drive, Bundoora, VIC 3083 Phone: (03) 9479 5159 Website: www.adalta.com.au
|
Communication person with ASX: |
Samantha Kathleen Cobb |
Share registry: |
Automic Registry Services Suite 310, level 3, 50 Holt Street Surrey Hills, NSW 2010 |
Balance date: |
30 June |
CHESS: |
Participating. The Company will also operate an issuer sponsored sub-register. |
Place of incorporation: |
Victoria |
Dividend policy: |
See page 49 of the Prospectus. |
Activities: |
Drug discovery & development |
Restricted securities: |
22,997,291 fully paid ordinary shares escrowed for a period of 24 month from the date of official quotation.
1,406,241 options exerciseable at various prices expiring various dates escrowed for a period of 24 months from the date of official quotation.
576,967 fully paid ordinary shares escrowed until 23 February 2017.
|
Securities not quoted: |
738,182 options exerciseable at various prices expiring various dates. |
Please refer to the Company’s Prospectus and website for further information.
Kate Kidson, Principal Adviser, Listings Compliance (Melbourne)
Kate Kidson
+61 (03) 9617 8772
info@asx.com.au